Quantamental Technologies’s Chemours CC Stock Holding History

Quantamental Technologies’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-12,352	Closed	-$258K	–	125
2020 Q3	$258K	Buy	+12,352	New	+$238K	0.19%	181
2019 Q3	–	Sell	-696	Closed	-$17K	–	1551
2019 Q2	$17K	Buy	696 +512	+278%	+$15.1K	0.01%	1162
2019 Q1	$7K	Buy	+184	New	+$6.7K	﹤0.01%	1271

Other funds holding CC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

Quantamental Technologies's CC Position: Q4 2020 in Review

Quantamental Technologies sold out of Chemours (CC) in Q4 2020, closing a stake of 12,352 shares — an estimated $258K sold.

Quantamental Technologies first reported a position in CC in Q1 2019 and held it in 3 quarters. The position peaked at $258K in Q3 2020. 429 funds tracked by Wall St. Rank hold CC as of Q4 2020.

Quantamental Technologies reported no remaining Chemours position as of Q4 2020 after selling out during the quarter.
Quantamental Technologies sold 12,352 Chemours shares in Q4 2020, an estimated $258K.
Quantamental Technologies first reported a position in Chemours in Q1 2019 and held it in 3 quarters.
Quantamental Technologies's Chemours position peaked at $258K in Q3 2020.
429 funds tracked by Wall St. Rank held Chemours as of Q4 2020.

Based on Quantamental Technologies's 13F filing for Q4 2020, filed 16 Feb 2021.